Cargando…

Synthetic Toll-like Receptors 7 and 8 Agonists: Structure–Activity Relationship in the Oxoadenine Series

[Image: see text] Toll-like receptors 7 and 8 (TLR7/8) are broadly expressed on antigen-presenting cells, making TLR7/8 agonists likely candidates for the development of new vaccine adjuvants. We previously reported the synthesis of a new series of 8-oxoadenines substituted at the 9-position with a...

Descripción completa

Detalles Bibliográficos
Autores principales: Evans, Jay T., Bess, Laura S., Mwakwari, Sandra C., Livesay, Mark T., Li, Yufeng, Cybulski, Van, Johnson, David A., Bazin, Hélène G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2019
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761749/
https://www.ncbi.nlm.nih.gov/pubmed/31572869
http://dx.doi.org/10.1021/acsomega.9b02138
_version_ 1783454087521501184
author Evans, Jay T.
Bess, Laura S.
Mwakwari, Sandra C.
Livesay, Mark T.
Li, Yufeng
Cybulski, Van
Johnson, David A.
Bazin, Hélène G.
author_facet Evans, Jay T.
Bess, Laura S.
Mwakwari, Sandra C.
Livesay, Mark T.
Li, Yufeng
Cybulski, Van
Johnson, David A.
Bazin, Hélène G.
author_sort Evans, Jay T.
collection PubMed
description [Image: see text] Toll-like receptors 7 and 8 (TLR7/8) are broadly expressed on antigen-presenting cells, making TLR7/8 agonists likely candidates for the development of new vaccine adjuvants. We previously reported the synthesis of a new series of 8-oxoadenines substituted at the 9-position with a 4-piperidinylalkyl moiety and demonstrated that TLR7/8 selectivity and potency could be modulated by varying the length of the alkyl linker. In the present study, we broadened our initial structure–activity relationship study to further evaluate the effects of N-heterocycle ring size, chirality, and substitution on TLR7/8 potency, receptor selectivity, and cytokine (IFNα and TNFα) induction from human peripheral blood mononuclear cells (PBMCs). TLR7/8 activity correlated primarily to linker length and to a lesser extent to ring size, while ring chirality had little effect on TLR7/8 potency or selectivity. Substitution of the heterocyclic ring with an aminoalkyl or hydroxyalkyl group for subsequent conjugation to phospholipids or antigens was well tolerated with the retention of both TLR7/8 activity and cytokine induction from human PBMCs.
format Online
Article
Text
id pubmed-6761749
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-67617492019-09-30 Synthetic Toll-like Receptors 7 and 8 Agonists: Structure–Activity Relationship in the Oxoadenine Series Evans, Jay T. Bess, Laura S. Mwakwari, Sandra C. Livesay, Mark T. Li, Yufeng Cybulski, Van Johnson, David A. Bazin, Hélène G. ACS Omega [Image: see text] Toll-like receptors 7 and 8 (TLR7/8) are broadly expressed on antigen-presenting cells, making TLR7/8 agonists likely candidates for the development of new vaccine adjuvants. We previously reported the synthesis of a new series of 8-oxoadenines substituted at the 9-position with a 4-piperidinylalkyl moiety and demonstrated that TLR7/8 selectivity and potency could be modulated by varying the length of the alkyl linker. In the present study, we broadened our initial structure–activity relationship study to further evaluate the effects of N-heterocycle ring size, chirality, and substitution on TLR7/8 potency, receptor selectivity, and cytokine (IFNα and TNFα) induction from human peripheral blood mononuclear cells (PBMCs). TLR7/8 activity correlated primarily to linker length and to a lesser extent to ring size, while ring chirality had little effect on TLR7/8 potency or selectivity. Substitution of the heterocyclic ring with an aminoalkyl or hydroxyalkyl group for subsequent conjugation to phospholipids or antigens was well tolerated with the retention of both TLR7/8 activity and cytokine induction from human PBMCs. American Chemical Society 2019-09-10 /pmc/articles/PMC6761749/ /pubmed/31572869 http://dx.doi.org/10.1021/acsomega.9b02138 Text en Copyright © 2019 American Chemical Society This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes.
spellingShingle Evans, Jay T.
Bess, Laura S.
Mwakwari, Sandra C.
Livesay, Mark T.
Li, Yufeng
Cybulski, Van
Johnson, David A.
Bazin, Hélène G.
Synthetic Toll-like Receptors 7 and 8 Agonists: Structure–Activity Relationship in the Oxoadenine Series
title Synthetic Toll-like Receptors 7 and 8 Agonists: Structure–Activity Relationship in the Oxoadenine Series
title_full Synthetic Toll-like Receptors 7 and 8 Agonists: Structure–Activity Relationship in the Oxoadenine Series
title_fullStr Synthetic Toll-like Receptors 7 and 8 Agonists: Structure–Activity Relationship in the Oxoadenine Series
title_full_unstemmed Synthetic Toll-like Receptors 7 and 8 Agonists: Structure–Activity Relationship in the Oxoadenine Series
title_short Synthetic Toll-like Receptors 7 and 8 Agonists: Structure–Activity Relationship in the Oxoadenine Series
title_sort synthetic toll-like receptors 7 and 8 agonists: structure–activity relationship in the oxoadenine series
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761749/
https://www.ncbi.nlm.nih.gov/pubmed/31572869
http://dx.doi.org/10.1021/acsomega.9b02138
work_keys_str_mv AT evansjayt synthetictolllikereceptors7and8agonistsstructureactivityrelationshipintheoxoadenineseries
AT besslauras synthetictolllikereceptors7and8agonistsstructureactivityrelationshipintheoxoadenineseries
AT mwakwarisandrac synthetictolllikereceptors7and8agonistsstructureactivityrelationshipintheoxoadenineseries
AT livesaymarkt synthetictolllikereceptors7and8agonistsstructureactivityrelationshipintheoxoadenineseries
AT liyufeng synthetictolllikereceptors7and8agonistsstructureactivityrelationshipintheoxoadenineseries
AT cybulskivan synthetictolllikereceptors7and8agonistsstructureactivityrelationshipintheoxoadenineseries
AT johnsondavida synthetictolllikereceptors7and8agonistsstructureactivityrelationshipintheoxoadenineseries
AT bazinheleneg synthetictolllikereceptors7and8agonistsstructureactivityrelationshipintheoxoadenineseries